IECM
CDMO

Intrinsic Edge Capital Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Intrinsic Edge Capital Management’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-150,000
Closed -$3.85M – 279
2021
Q2 		$3.85M Buy
+150,000
New +$3.2M 0.23% 152

Other funds holding CDMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return

Intrinsic Edge Capital Management's CDMO Position: Q3 2024 in Review

Intrinsic Edge Capital Management sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q3 2024, closing a stake of 100,000 shares — an estimated $714K sold.

Intrinsic Edge Capital Management first reported a position in CDMO in Q4 2020 and held it in 5 quarters. The position peaked at $5.15M in Q2 2021. 172 funds tracked by Wall St. Rank hold CDMO as of Q3 2024.

  • Intrinsic Edge Capital Management reported no remaining Avid Bioservices, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Intrinsic Edge Capital Management sold 100,000 Avid Bioservices, Inc. Common Stock shares in Q3 2024, an estimated $714K.
  • Intrinsic Edge Capital Management first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2020 and held it in 5 quarters.
  • Intrinsic Edge Capital Management's Avid Bioservices, Inc. Common Stock position peaked at $5.15M in Q2 2021.
  • 172 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q3 2024.

Based on Intrinsic Edge Capital Management's 13F filing for Q3 2024, filed 8 Nov 2024.